Hepcludex FDA Approval: First Treatment for Hepatitis D
Review the FDA accelerated approval of Hepcludex (bulevirtide) for chronic hepatitis delta virus (HDV), including clinical trial data and public health impact.
Back to Articles
Articles tagged with “hdv-treatment”